Liposomes for (trans)dermal drug delivery: the skin-PVPA as a novel in vitro stratum corneum model in formulation development

References

• Barry BW. (2001). Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 14:101–14
   PubMed Web of Science ®Google Scholar
• Bartlett GR. (1959). Phosphorus assay in column chromatography. J Biol Chem 234:466–8
   PubMed Web of Science ®Google Scholar
• Cadena PG, Pereira MA, Cordeiro RB, et al. (2013). Nanoencapsulation of quercetin and resveratrol into elastic liposomes. Biochim Biophys Acta 1828:309–16
   PubMed Web of Science ®Google Scholar
• Cereda CM, Franz-Montan M, da Silva CM, et al. (2013). Transdermal delivery of butamben using elastic and conventional liposomes. J Liposome Res 23:228–34
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. (1992). Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1104:226–32
   PubMed Web of Science ®Google Scholar
• Cevc G, Gebauer D, Stieber J, et al. (1998). Ultraflexible vesicles, transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta 1368:201–15
   PubMed Web of Science ®Google Scholar
• Cevc G, Schatzlein A, Richardsen H. (2002). Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim Biophys Acta 1564:21–30
   PubMed Web of Science ®Google Scholar
• Cevc G, Vierl U. (2010). Nanotechnology and the transdermal route: a state of the art review and critical appraisal. J Control Release 141:277–99
   PubMed Web of Science ®Google Scholar
• Chen Y, Lu Y, Chen J, et al. (2009). Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. Int J Pharm 376:153–60
   PubMed Web of Science ®Google Scholar
• Chilcott RP, Barai N, Beezer AE, et al. (2005). Inter- and intralaboratory variation of in vitro diffusion cell measurements: an international multicenter study using quasi-standardized methods and materials. J Pharm Sci 94:632–8
   PubMed Web of Science ®Google Scholar
• Delgado-Charro MB, Guy RH. (2001). Transdermal drug delivery. In: Hillery AM, Lloyd AW, Swarbrick J, eds. Drug delivery and targeting for pharmacists and pharmaceutical scientists. London-New York: Taylor & Francis, 208–36
   Google Scholar
• Dragicevic-Curic N, Scheglmann D, Albrecht V, Fahr A. (2008). Temoporfin-loaded invasomes: development, characterization and in vitro skin penetration studies. J Control Release 127:59–69
   PubMed Web of Science ®Google Scholar
• El Maghraby GM, Williams AC, Barry BW. (2006). Can drug-bearing liposomes penetrate intact skin? J Pharm Pharmacol 58:415–29
   PubMed Web of Science ®Google Scholar
• El Zaafarany GM, Awad GA, Holayel SM, Mortada ND. (2010). Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm 397:164–72
   PubMed Web of Science ®Google Scholar
• Elmoslemany RM, Abdallah OY, El-Khordagui LK, Khalafallah NM. (2012). Propylene glycol liposomes as a topical delivery system for miconazole nitrate: comparison with conventional liposomes. AAPS PharmSciTech 13:723–31
   PubMed Web of Science ®Google Scholar
• Elsayed MMA, Abdallah OY, Naggar VF, Khalafallah NM. (2007a). PG-liposomes: novel lipid vesicles for skin delivery of drugs. J Pharm Pharmacol 59:1447–50
   PubMed Web of Science ®Google Scholar
• Elsayed MMA, Abdallah OY, Naggar VF, Khalafallah NM. (2007b). Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm 332:1–16
   PubMed Web of Science ®Google Scholar
• Engesland A, Skar M, Hansen T, et al. (2013). New applications of phospholipid vesicle-based permeation assay: permeation model mimicking skin barrier. J Pharm Sci 102:1588–600
   PubMed Web of Science ®Google Scholar
• Ferderber K, Hook S, Rades T. (2009). Phosphatidyl choline-based colloidal systems for dermal and transdermal drug delivery. J Liposome Res 19:267–77
   PubMed Web of Science ®Google Scholar
• Flaten GE, Bunjes H, Luthman K, Brandl M. (2006a). Drug permeability across a phospholipid vesicle-based barrier 2. Characterization of barrier structure, storage stability and stability towards pH changes. Eur J Pharm Sci 28:336–43
   PubMed Web of Science ®Google Scholar
• Flaten GE, Dhanikula AB, Luthman K, Brandl M. (2006b). Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion. Eur J Pharm Sci 27:80–90
   PubMed Web of Science ®Google Scholar
• Flaten GE, Skar M, Luthman K, Brandl M. (2007). Drug permeability across a phospholipid vesicle based barrier: characterization of drug-membrane interactions and the effect of agitation on the barrier integrity and on the permeability. Eur J Pharm Sci 30:324–32
   PubMed Web of Science ®Google Scholar
• Ghanbarzadeh S, Arami S. (2013). Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transferosomes. BioMed Res Int 2013:1–7
   Web of Science ®Google Scholar
• Gillet A, Compere P, Lecomte F, et al. (2011a). Liposome surface charge influence on skin penetration behavior. Int J Pharm 411:223–31
   PubMed Web of Science ®Google Scholar
• Gillet A, Lecomte F, Hubert P, et al. (2011b). Skin penetration behaviour of liposomes as a function of their composition. Eur J Pharm Biopharm 79:43–53
   PubMed Web of Science ®Google Scholar
• Herkenne C, Naik A, Kalia YN, et al. (2007). Ibuprofen transport into and through skin from topical formulations: in vitro–in vivo comparison. J Invest Dermatol 127:135–42
   PubMed Web of Science ®Google Scholar
• Honeywell-Nguyen PL, Bouwstra JA. (2005). Vesicles as a tool for tansdermal and dermal delivery. Drug Discov Today Technol 2:67–74
   PubMedGoogle Scholar
• Hurler J, Berg OA, Skar M, et al. (2012). Improved burns therapy: liposomes-in-hydrogel delivery system for mupirocin. J Pharm Sci 101:3906–15
   PubMed Web of Science ®Google Scholar
• Jain S, Jain P, Umamaheshwari RB, Jain NK. (2003). Transfersomes – a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Ind Pharm 29:1013–26
   PubMed Web of Science ®Google Scholar
• Kanzer J, Tho I, Flaten GE, et al. (2010). In-vitro permeability screening of melt-estrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier. J Pharm Pharmacol 62:1591–8
   PubMed Web of Science ®Google Scholar
• Kawano K, Onose E, Hattori Y, Maitani Y. (2009). Higher liposomal membrane fluidity enhances the in vitro antitumor activity of folate-targeted liposomal mitoxantrone. Mol Pharm 6:98–104
   PubMed Web of Science ®Google Scholar
• Kikuchi H, Yamauchi H, Hirota S. (1994). A polyol dilution method for mass production of liposomes. J Liposome Res 4:71–91
   Web of Science ®Google Scholar
• Lane ME. (2013). Skin penetration enhancers. Int J Pharm 447:12–21
   PubMed Web of Science ®Google Scholar
• Manconi M, Mura S, Sinico C, et al. (2009). Development and characterization of liposomes containing glycols as carriers for diclofenac. Colloid Surface A 342:53–8
   Web of Science ®Google Scholar
• Oliveira G, Beezer AE, Hadgraft J, Lane ME. (2010). Alcohol enhanced permeation in model membranes. Part I. Thermodynamic and kinetic analyses of membrane permeation. Int J Pharm 393:61–7
   PubMed Web of Science ®Google Scholar
• Pavelić Ž, Škalko-Basnet N, Filipović-Grčić J, et al. (2005). Development and in vitro evaluation of a liposomal vaginal delivery system for acyclovir. J Control Release 106:34–43
   PubMed Web of Science ®Google Scholar
• Prow TW, Grice JE, Lin LL, et al. (2011). Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev 63:470–91
   PubMed Web of Science ®Google Scholar
• Salerno C, Carlucci AM, Bregni C. (2010). Study of in vitro drug release and percutaneous absorption of fluconazole from topical dosage forms. AAPS Pharm Sci Tech 11:986–93
   PubMed Web of Science ®Google Scholar
• Sinko B, Garrigues TM, Balogh GT, et al. (2012). Skin-PAMPA: a new method for fast prediction of skin penetration. Eur J Pharm Sci 45:698–707
   PubMed Web of Science ®Google Scholar
• Subongkot T, Duangjit S, Rojanarata T, et al. (2012). Ultradeformable liposomes with terpenes for delivery of hydrophilic compound. J Liposome Res 22:254–62
   PubMed Web of Science ®Google Scholar
• Šentjurc M, Vrhovnik K, Kristl J. (1999). Liposomes as a topical delivery system: the role of size on transport studied by the EPR imaging method. J Control Release 59:87–97
   PubMed Web of Science ®Google Scholar
• Touitou E, Dayan N, Bergelson L, et al. (2000). Ethosomes – novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 65:403–18
   PubMed Web of Science ®Google Scholar
• Vanić Ž, Barnert S, Süss R, Schubert R. (2012). Fusogenic activity of PEGylated pH-sensitive liposomes. J Liposome Res 22:148–57
   PubMed Web of Science ®Google Scholar
• Vanić Ž, Hafner A, Bego M, Škalko-Basnet N. (2013). The characterization of various deformable liposomes with metronidazole. Drug Dev Ind Pharm 39:481–8
   PubMed Web of Science ®Google Scholar
• Vanić Ž, Hurler J, Ferderber K, et al. (2014). Novel vaginal drug delivery system: deformable propylene glycol liposomes-in-hydrogel. J Liposome Res 24:27–36
   PubMed Web of Science ®Google Scholar
• Verma DD, Verma S, Blume G, Fahr A. (2003). Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm 258:141–51
   PubMed Web of Science ®Google Scholar
• Zhao YZ, Dai DD, Lu CT, et al. (2013). Epirubicin loaded with propylene glycol liposomes significantly overcomes multidrug resistance in breast cancer. Cancer Lett 330:74–83
   PubMed Web of Science ®Google Scholar